Delcath Systems (DCTH) Receivables Refunds (2012 - 2018)
Delcath Systems' quarterly Receivables Refunds came in at $145000.0 in Q3 2018, up 400.0% quarter-over-quarter from $29000.0 in Q4 2017.
Delcath Systems has reported Receivables Refunds for 5 years, with the latest figure at $145000.0 in Q3 2018.
- For the quarter ending Q3 2018, Receivables Refunds changed N/A year-over-year to $145000.0; the trailing twelve-month figure through Sep 2018 stood at $145000.0 (changed N/A YoY), and the FY2017 full-year result was $29000.0, changed N/A from the prior year.
- Receivables Refunds for Q3 2018 stood at $145000.0, up from $29000.0 in the prior quarter.
- The five-year high for Receivables Refunds was $297000.0 in Q1 2014, with the low at $18000.0 in Q2 2014.
- Average Receivables Refunds over 3 years is $122250.0, with a median of $87000.0 recorded in 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 52.68 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 145,000.00 |
| Dec 31, 2017 | 29,000.00 |
| Jun 30, 2014 | 18,000.00 |
| Mar 31, 2014 | 297,000.00 |
| Dec 31, 2013 | 326,000.00 |
| Dec 31, 2012 | 305,000.00 |